MetLife Investment Management’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$704K Sell
41,455
-299
-0.7% -$6.41K ﹤0.01% 1584
2025
Q4
$1.07M Sell
41,754
-1,820
-4% -$41.9K 0.01% 1387
2025
Q3
$938K Buy
43,574
+17
+0% +$386 ﹤0.01% 1486
2025
Q2
$958K Sell
43,557
-278
-0.6% -$6.1K 0.01% 1341
2025
Q1
$979K Sell
43,835
-8,056
-16% -$173K 0.01% 1380
2024
Q4
$895K Buy
51,891
+3,085
+6% +$47.9K ﹤0.01% 1476
2024
Q3
$818K Sell
48,806
-42,139
-46% -$1.01M ﹤0.01% 1504
2024
Q2
$2.6M Buy
90,945
+5,350
+6% +$161K 0.02% 859
2024
Q1
$3.27M Sell
85,595
-1,211
-1% -$45.8K 0.02% 735
2023
Q4
$3.23M Sell
86,806
-531
-0.6% -$17.8K 0.02% 729
2023
Q3
$2.97M Buy
87,337
+1,609
+2% +$60.7K 0.02% 713
2023
Q2
$3.37M Buy
85,728
+1,846
+2% +$66.6K 0.02% 690
2023
Q1
$2.69M Sell
83,882
-1,237
-1% -$40.9K 0.02% 796
2022
Q4
$2.65M Sell
85,119
-178
-0.2% -$6.43K 0.02% 778
2022
Q3
$3.16M Buy
85,297
+1,817
+2% +$68K 0.03% 660
2022
Q2
$2.43M Buy
83,480
+4,755
+6% +$170K 0.02% 825
2022
Q1
$4.05M Buy
78,725
+22,361
+40% +$958K 0.03% 660
2021
Q4
$2.84M Buy
56,364
+676
+1% +$37.8K 0.02% 699
2021
Q3
$3.12M Buy
55,688
+14,490
+35% +$800K 0.03% 617
2021
Q2
$2.43M Buy
41,198
+29,011
+238% +$1.63M 0.02% 787
2021
Q1
$542K Hold
12,187
0.01% 1479
2020
Q4
$517K Hold
12,187
﹤0.01% 1479
2020
Q3
$359K Hold
12,187
﹤0.01% 1541
2020
Q2
$315K Buy
12,187
+6,445
+112% +$148K ﹤0.01% 1629
2020
Q1
$122K Sell
5,742
-4,705
-45% -$129K ﹤0.01% 1973
2019
Q4
$287K Buy
+10,447
New +$250K ﹤0.01% 1782

Other funds holding PGNY

MetLife Investment Management's PGNY Position: Q1 2026 in Review

MetLife Investment Management reduced its Progyny (PGNY) stake by 0.72% in Q1 2026, selling an estimated $6.41K and leaving 41,455 shares worth $704K. The position accounts for ﹤0.01% of the portfolio, ranked #1584.

MetLife Investment Management first reported a position in PGNY in Q4 2019 and has held it in 26 quarters since. The position peaked at $4.05M in Q1 2022. 292 funds tracked by Wall St. Rank hold PGNY as of Q1 2026.

  • MetLife Investment Management held 41,455 shares of Progyny worth $704K as of Q1 2026.
  • MetLife Investment Management sold 299 Progyny shares in Q1 2026, an estimated $6.41K.
  • Progyny made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1584 holding.
  • MetLife Investment Management first reported a position in Progyny in Q4 2019 and has held it in 26 quarters since.
  • MetLife Investment Management's Progyny position peaked at $4.05M in Q1 2022.
  • 292 funds tracked by Wall St. Rank held Progyny as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.